All In Biotech

Drug Trial Radar · NCT05518578

Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy

RENAISSANCE Study: A Phase 2, Multicenter, Open Label Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy

Last checked: Nov 19, 2026Latest source record: Apr 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Feb 7, 2023

Primary completion

Dec 31, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
Supernus Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Aug 26, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the safety and tolerability of SPN-817 in adults with treatment resistant seizures

Conditions

  • Epilepsy
  • Seizures, Epileptic

Interventions

  • SPN-817Drug

    oral capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effects of SPN-817 on safety and tolerabilityTime frame: 72 weeks

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • Green Leaf Clinical Trials, LLC

    Jacksonville, Florida · Recruiting

  • Visionary Investigators Network

    Miami, Florida · Recruiting

  • Prince of Wales Hospital

    Randwick, New South Wales, Australia · Recruiting

  • Royal Prince Alfred Hospital

    Sydney, New South Wales, Australia · Completed

  • Westmead Hospital

    Sydney, New South Wales, Australia · Completed

  • Royal Brisbane and Women's Hospital

    Brisbane, Queensland, Australia · Recruiting

  • Box Hill Hospital

    Box Hill, Victoria, Australia · Recruiting

  • The Austin Hospital

    Heidelberg, Victoria, Australia · Recruiting

  • The Alfred Hospital

    Melbourne, Victoria, Australia · Recruiting

  • The Royal Melbourne Hospital

    Parkville, Victoria, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.